Financial Counselors Inc Abb Vie Inc. Transaction History

Financial Counselors Inc

$6.18 Billion
Q2 2024

A detailed history of Financial Counselors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Counselors Inc holds 471,807 shares of ABBV stock, worth $91 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

471,807

Previous 463,740 1.74%

Holding current value

$91 Million

Previous $84.4 Million 4.17%

% of portfolio

1.31%

Previous 1.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $1.25 Million - $1.46 Million	8,067 Added 1.74%	471,807 $80.9 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $5.01 Million - $5.71 Million	31,375 Added 7.26%	463,740 $84.4 Million
Q4 2023 Jan 26, 2024	BUY	$137.6 - $154.97 $144,204 - $162,408	1,048 Added 0.24%	432,365 $67 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $438,843 - $508,025	3,285 Added 0.77%	431,317 $64.3 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $251,106 - $312,485	1,895 Added 0.44%	428,032 $57.7 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $360,657 - $415,350	-2,494 Reduced 0.58%	426,137 $67.9 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $129,458 - $155,254	-936 Reduced 0.22%	428,631 $69.3 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $143,336 - $164,397	1,068 Added 0.25%	429,567 $57.7 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $3.3 Million - $4.2 Million	-24,014 Reduced 5.31%	428,499 $65.6 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $1.47 Million - $1.82 Million	11,119 Added 2.52%	452,513 $73.4 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $2.92 Million - $3.69 Million	-27,144 Reduced 5.79%	441,394 $59.8 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $1.36 Million - $1.54 Million	12,785 Added 2.81%	468,538 $50.5 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $719,952 - $802,068	6,843 Added 1.52%	455,753 $51.3 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $97,287 - $107,101	951 Added 0.21%	448,910 $48.6 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $2.18 Million - $2.95 Million	27,108 Added 6.44%	447,959 $48 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $2.6 Million - $3.05 Million	30,237 Added 7.74%	420,851 $36.9 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $4.8 Million - $6.42 Million	65,441 Added 20.12%	390,614 $38.4 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $1.93 Million - $2.93 Million	29,919 Added 10.13%	325,173 $24.8 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $1.81 Million - $2.26 Million	25,052 Added 9.27%	295,254 $26.1 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $1.49 Million - $1.79 Million	23,627 Added 9.58%	270,202 $20.5 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $928,341 - $1.19 Million	14,130 Added 6.08%	246,575 $17.9 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.07 Million - $1.26 Million	13,881 Added 6.35%	232,445 $18.7 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $229,579 - $283,133	-2,949 Reduced 1.33%	218,564 $20.1 Million
Q3 2018 Oct 30, 2018	BUY	$88.91 - $98.84 $1.45 Million - $1.61 Million	16,307 Added 7.95%	221,513 $21 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $925,811 - $1.1 Million	10,312 Added 5.29%	205,206 $19 Million
Q1 2018 Apr 26, 2018	SELL	$92.01 - $123.21 $3.64 Million - $4.87 Million	-39,524 Reduced 16.86%	194,894 $18.4 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $1.7 Million - $1.86 Million	-18,936 Reduced 7.47%	234,418 $22.7 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $35,902 - $45,859	-514 Reduced 0.2%	253,354 $22.5 Million
Q2 2017 Aug 10, 2017	BUY	N/A	253,868	253,868 $18.4 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Abb Vie Inc. Transaction History